Genetic dissection of the control of normal differentiation in myeloid leukemic cells.
Normal myeloid precursors and MGI(+)D(+) myeloid leukemic cells can be induced to differentiate to mature cells by the normal protein inducer MGI. The sequence of differentiation is the induction of C3 and Fc rosettes, C3 and Fc immune phagocytosis (IP), synthesis and secretion of lysozyme, and formation of mature macrophages and granulocytes. Mutant clones of myeloid leukemic cells have been isolated with differences in the time of induction of C3 and Fc rosettes and C3 and Fc IP, in which lysozyme was induced without going through the stage of Fc or C3 IP, and with differences in inducibility by MGI to mature macrophages or granulocytes. Only one out of five MGI(-)D(-) clones gave rise to MGI(+)D(+) mutants. The ability to obtain mutants from this clone was associated with its special chromosome constitution, and these mutants showed a change in their ability for cap formation by concanavalin A. The steroid inducer dexamethasone can induce in MGI(+)D(+) clones differentiation to macrophages but not to granulocytes. Differentiation by steroid inducer in different clones occurred either with or without induction of Fc rosettes and Fc IP, and induction of C3 rosettes was not always associated with induction of C3 IP. The use of mutants that differ in their competence to be induced by MGI or steroid inducer has shown that there are separate controls for the induction of C3 and Fc rosettes, C3 and Fc IP, lysozyme, macrophages, and granulocytes.
D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D003176:Complement C3 / Q000378:metabolism; D006098:Granulocytes / Q000166:cytology; D007141:Immunoglobulin Fc Fragments / Q000378:metabolism; D007152:Immunologic Capping; D007942:Leukemia, Experimental / Q000235:genetics / Q000473:pathology; D007951:Leukemia, Myeloid / Q000235:genetics / Q000473:pathology*; D008264:Macrophages / Q000166:cytology; D009113:Muramidase / Q000378:metabolism; D010587:Phagocytosis; D012397:Rosette Formation
D003176:Complement C3; D007141:Immunoglobulin Fc Fragments; D009113:Muramidase
J Natl Cancer Inst. 1963 Jul;31:1-39
14043037
Proc Natl Acad Sci U S A. 1977 Mar;74(3):1100-4
265555
J Cell Physiol. 1977 Jul;92(1):97-108
197112
Proc Natl Acad Sci U S A. 1977 Jan;74(1):253-7
264678
Cell. 1976 Dec;9(4 PT 2):675-84
1017012
J Cell Physiol. 1976 Oct;89(2):259-66
972167
Exp Cell Res. 1974 Oct;88(2):257-62
4529737
Aust J Exp Biol Med Sci. 1966 Jun;44(3):287-99
4164182
J Cell Physiol. 1969 Dec;74(3):223-34
4187945
J Cell Physiol. 1971 Apr;77(2):121-34
5572424
J Exp Med. 1970 Oct 1;132(4):702-20
4101362
Proc Natl Acad Sci U S A. 1976 Apr;73(4):1232-6
177980
Harvey Lect. 1974;68:1-35
4375672
Annu Rev Biochem. 1974;43(0):169-214
4368906
Proc Natl Acad Sci U S A. 1971 Oct;68(10):2540-4
4332814
Proc Natl Acad Sci U S A. 1973 May;70(5):1442-6
4514314
Proc Natl Acad Sci U S A. 1973 Feb;70(2):343-6
4510279
Proc Natl Acad Sci U S A. 1974 Sep;71(9):3507-11
4530318
J Cell Physiol. 1975 Jun;85(3):587-94
124742
J Exp Med. 1974 May 1;139(5):1228-48
4825244
J Exp Med. 1972 Apr 1;135(4):780-92
5018051
Proc Natl Acad Sci U S A. 1971 Feb;68(2):378-82
5277089
Int J Cancer. 1975 May 15;15(5):731-40
1079793
J Immunol. 1976 Aug;117(2):580-6
950462
Proc Natl Acad Sci U S A. 1976 Jan;73(1):188-92
1061115
J Immunol. 1976 Apr;116(4):892-7
1254970
J Cell Physiol. 1975 Oct;86(2 Pt 1):221-30
1194362
Proc Natl Acad Sci U S A. 1970 Nov;67(3):1542-9
5274478
J Exp Med. 1975 Jun 1;141(6):1278-90
1127381
Proc Natl Acad Sci U S A. 1966 Aug;56(2):488-95
5229970
J Cell Physiol. 1969 Dec;74(3):323-32
5390860
Exp Cell Res. 1966 Oct;43(3):553-63
5957746
J Cell Physiol. 1965 Dec;66(3):319-24
5884359